NO20011403D0 - Terapi for Õ forbedre kongestion - Google Patents
Terapi for Õ forbedre kongestionInfo
- Publication number
- NO20011403D0 NO20011403D0 NO20011403A NO20011403A NO20011403D0 NO 20011403 D0 NO20011403 D0 NO 20011403D0 NO 20011403 A NO20011403 A NO 20011403A NO 20011403 A NO20011403 A NO 20011403A NO 20011403 D0 NO20011403 D0 NO 20011403D0
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- improve congestion
- congestion
- improve
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203454 | 1998-10-16 | ||
| PCT/EP1999/007804 WO2000023057A2 (fr) | 1998-10-16 | 1999-10-12 | Therapie visant a ameliorer la cognition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011403D0 true NO20011403D0 (no) | 2001-03-20 |
| NO20011403L NO20011403L (no) | 2001-03-20 |
Family
ID=8234219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011403A NO20011403L (no) | 1998-10-16 | 2001-03-20 | Terapi for å forbedre kongestion |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1121131A2 (fr) |
| JP (1) | JP2002527469A (fr) |
| KR (1) | KR20010072878A (fr) |
| CN (1) | CN1367697A (fr) |
| AU (1) | AU6472799A (fr) |
| BG (1) | BG105302A (fr) |
| BR (1) | BR9914419A (fr) |
| CA (1) | CA2345767A1 (fr) |
| EE (1) | EE200100136A (fr) |
| HK (1) | HK1039745A1 (fr) |
| HR (1) | HRP20010262A2 (fr) |
| HU (1) | HUP0103781A3 (fr) |
| ID (1) | ID28441A (fr) |
| IL (1) | IL142588A0 (fr) |
| NO (1) | NO20011403L (fr) |
| PL (1) | PL348107A1 (fr) |
| SK (1) | SK4592001A3 (fr) |
| TR (1) | TR200101082T2 (fr) |
| WO (1) | WO2000023057A2 (fr) |
| ZA (1) | ZA200103081B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
| GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
| CA2463158C (fr) | 2001-10-30 | 2013-07-30 | Novartis Ag | Preparations de depot d'iloperidone et de polymere en etoile |
| GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
| WO2004084905A2 (fr) * | 2003-03-24 | 2004-10-07 | University Of Florida | Methodes de traitement de l'hyperhidrose idiopathique et de pathologies associees |
| TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
| EP1824848A1 (fr) * | 2004-12-10 | 2007-08-29 | Abbott Laboratories | Derives polycycliques de quinuclidine substitues par un bicycloheterocycle condense |
| CA2552221A1 (fr) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Formulations de donepezil |
| EP2089383B1 (fr) | 2006-11-09 | 2015-09-16 | Probiodrug AG | Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies |
| US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| EP2481408A3 (fr) | 2007-03-01 | 2013-01-09 | Probiodrug AG | Nouvelle utilisation d'inhibiteurs glutaminyle cyclase |
| WO2008128985A1 (fr) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase |
| MX2007008642A (es) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias. |
| CN102905532A (zh) | 2010-02-09 | 2013-01-30 | 约翰斯.霍普金斯大学 | 用于改善认知功能的方法和组合物 |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| NZ602312A (en) | 2010-03-10 | 2014-02-28 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| EP2686313B1 (fr) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Dérivés de benzimidazole en tant qu'inhibiteurs de la glutaminyl cyclase |
| EP3610890A1 (fr) | 2012-11-14 | 2020-02-19 | The Johns Hopkins University | Procédés et compositions de traitement de la schizophrénie |
| CN105142623A (zh) | 2013-03-15 | 2015-12-09 | 艾吉因生物股份有限公司 | 用于改善认知功能的方法和组合物 |
| EP2968237A4 (fr) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | Procédés et compositions pour améliorer la fonction cognitive |
| US10159648B2 (en) | 2015-05-22 | 2018-12-25 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0584185T3 (da) * | 1991-05-14 | 2000-02-07 | Ernir Snorrason | Behandling af træthedssyndrom med cholinesteraseinhibitorer |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| JP4640888B2 (ja) * | 1997-08-11 | 2011-03-02 | ザ ユニヴァーシティー オブ サウス フロリダ | 神経精神性疾患用ニコチンアンタゴニスト |
| DE69936848T2 (de) * | 1998-04-14 | 2008-05-15 | The General Hospital Corp., Boston | Verwendung von d-serin oder d-alanin zur behandlung von schizophrenie |
-
1999
- 1999-10-12 CA CA002345767A patent/CA2345767A1/fr not_active Abandoned
- 1999-10-12 HK HK02100158.6A patent/HK1039745A1/zh unknown
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/fr not_active Ceased
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 EP EP99952580A patent/EP1121131A2/fr not_active Withdrawn
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Withdrawn
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/no not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9914419A (pt) | 2001-06-26 |
| CA2345767A1 (fr) | 2000-04-27 |
| SK4592001A3 (en) | 2001-12-03 |
| ID28441A (id) | 2001-05-24 |
| NO20011403L (no) | 2001-03-20 |
| PL348107A1 (en) | 2002-05-06 |
| EP1121131A2 (fr) | 2001-08-08 |
| BG105302A (en) | 2001-11-30 |
| KR20010072878A (ko) | 2001-07-31 |
| HUP0103781A2 (hu) | 2002-03-28 |
| WO2000023057A2 (fr) | 2000-04-27 |
| WO2000023057A3 (fr) | 2000-07-27 |
| AU6472799A (en) | 2000-05-08 |
| JP2002527469A (ja) | 2002-08-27 |
| IL142588A0 (en) | 2002-03-10 |
| TR200101082T2 (tr) | 2001-09-21 |
| HK1039745A1 (zh) | 2002-05-10 |
| ZA200103081B (en) | 2002-07-12 |
| HUP0103781A3 (en) | 2003-09-29 |
| CN1367697A (zh) | 2002-09-04 |
| EE200100136A (et) | 2002-06-17 |
| HRP20010262A2 (en) | 2002-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20011403D0 (no) | Terapi for Õ forbedre kongestion | |
| IS6340A (is) | Vatnsgel-knúið lyfjaskammtaform | |
| ID27841A (id) | Turunan-turunan biaril terapeutik | |
| NO20003640D0 (no) | Ny doseringsform | |
| DE59910140D1 (de) | Gleitschalungsfertiger | |
| ID26974A (id) | Ketoenol siklik arilfenil-tersubstitusi | |
| DK1637127T3 (da) | Terapeutisk mikroskum | |
| NO992692D0 (no) | Nefadozon doseringsform | |
| DE69941252D1 (de) | Geriffelte elektroden | |
| DE69924365D1 (de) | Massagegerät | |
| ATE321483T1 (de) | Dose | |
| FR2806140B1 (fr) | Volant divise | |
| DE69936958D1 (de) | Verkehrsformer | |
| IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
| ID28648A (id) | Perangkat penyerapan inter-labial | |
| DE69921571D1 (de) | Massagegerät | |
| EE200200568A (et) | Ravis kasutatavad difenüüleetriühendid | |
| IS6574A (is) | Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka | |
| DE60037935D1 (de) | Kontinuierliches behandlungssystem | |
| NO20005042D0 (no) | FremgangsmÕter for Õ inhibere MRP1 | |
| NO994872D0 (no) | Reisesafe | |
| IT1310385B1 (it) | Dispositivo per migliorare la respirazione. | |
| NO20023164L (no) | Buekonstruksjon | |
| IS5877A (is) | Ný efnablanda | |
| IS5879A (is) | Ný efnablanda |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |